41 /100
MEDIUM RISK
Score updated May 30, 2026

GNTA — Genenta Science S.p.A. Dilution Risk Tracker

Track GNTA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GNTA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
52
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
54%
🔁 Convertible Conversion 60%
• Major convertible overhang: 31% potential dilution
• Convertible risk score very high (85/100)
🔄 Reverse Split 55%
• 50-day avg $0.69 below $1 exchange minimum
📉 Score Deterioration 40%
• Score rose 17 points recently (worsening)
🔔 Track GNTA — Get forecast alerts →

💹 Market Data

Market Cap$24.30M
Shares Outstanding23.59M
Float13.87M
Cash$32.82M
Debt$8.86M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 409.8% shares (2025Q4 vs prior)
15 institutional holders · 2.81M shares
#1 CITADEL ADVISORS LLC 655.2K shares
#2 Eurizon Capital SGR S.p.A. 360.0K shares
#3 Ghisallo Capital Management LLC 323.8K shares
+ 12 more holders Sign up free to view →

📉 Short Interest

Short Interest6.1K
Days to Cover1.0
% of Float0.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Jun 30, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track GNTA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GNTA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for GNTA
📊 GNTA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GNTA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.